At the Busunga crossing between Uganda and the Democratic Republic of Congo, a health officer systematically checks a traveler's temperature with an infrared digital thermometer. This border checkpoint separates the global economy from a rapidly expanding biological crisis. The World Health Organization declared a new Ebola outbreak in Congo's Ituri province a public health emergency of international concern on Sunday. At least 131 deaths have been linked to the outbreak, with more than 500 suspected cases in a region vital to global mineral extraction.

The friction here is entirely biological, but the implications are macroeconomic. The outbreak is driven by the rare Bundibugyo strain, which circulated undetected for a "couple months" before being identified in blood samples on May 15. "The actual number of cases may exceed 800," noted an analysis by researchers at Imperial College London, warning the toll could hit 1,000 in a worst-case scenario. There are no approved therapeutics or vaccines for this specific variant.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus stated he is "deeply concerned about the scale and speed" of the transmission. For global capital, the concern is the geography. Ituri is a critical gold-mining hub and a transit corridor for the broader Central African raw materials complex.

Pharmaceutical mitigations remain quarters away. "The most promising potential vaccine for the Bundibugyo strain is similar to the Merck shot," said Vasee Moorthy, a WHO senior advisor, noting it will take six to nine months to reach clinical trials. Until then, extraction companies operating in the DRC must price the extreme thermodynamic friction of operating a human labor force amid a lethal, untreatable hemorrhagic fever.